CVS Health stock received a positive adjustment to its Relative Strength (RS) Rating, from 70 to 73. Please watch the video ...

We recently published a list of the 10 Best Performing Healthcare Stocks So Far in 2025. In this article, we are going to ...

CVS Health (NYSE:CVS – Free Report) had its price target lifted by JPMorgan Chase & Co. from $80.00 to $81.00 in a report ...

Despite a recent 45% rally, I maintain a 'Sell' view on CVS due to its underwhelming execution record and rising leverage ...

CVS Health (CVS) stock soared about 15% yesterday after posting upbeat fourth-quarter results, with revenues and earnings ...

On the positive side, CVS is a more diversified healthcare company than Walgreens. CVS isn't just a leading pharmacy chain ...

Deutsche Bank raised the firm’s price target on CVS Health (CVS) to $70 from $66 and keeps a Buy rating on the shares. The company issued a ...

CVS Health reported fourth-quarter revenue and profit that topped ... insulin prices Pfizer says drug for deadly cancer ...

(AP Photo/Nam Y. Huh, file) Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] CVS Health steered through rising costs in its insurance division to handily beat profit expectations ...

CVS Health (NYSE: CVS) is in the same boat ... So, can it avoid having to suspend its dividend? On the positive side, CVS is a more diversified healthcare company than Walgreens.